A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
01/1989
01/03/1989	CA1248024A1 Treatments employing drug-containing matrices for introduction into cellular lesion areas
01/03/1989	CA1247878A1 Combination lock, namely for safes
12/1988
12/29/1988	WO1988010310A1 Bovine granulocyte-macrophage colony stimulating factor
12/29/1988	WO1988010300A1 Heterologous viral peptide particle immunogens
12/29/1988	WO1988010299A1 A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
12/29/1988	WO1988010297A1 Cloning of mite allergens
12/29/1988	WO1988010295A1 MODIFIED FACTOR VII/VIIa
12/29/1988	WO1988010270A1 Urinary follicle stimulating hormone
12/29/1988	WO1988010269A1 Growth factors
12/29/1988	WO1988010268A1 Hexapeptide and pharmaceutical preparation based thereon for curing erosive-ulcerous injuries to the digestive tract
12/29/1988	WO1988010267A1 Synthetic peptides related to hiv-env proteins
12/29/1988	WO1988010266A1 Cysteine proteinase inhibitor
12/29/1988	WO1988010120A1 Treatment of autoimmune diseases by oral administration of autoantigens
12/29/1988	DE3719367A1 Use of active substances which influence the metabolism and/or the structural properties of collagen in orthodontics
12/28/1988	EP0297068A2 Mammal intestine hormone precursor
12/28/1988	EP0297066A1 Novel fibrinolytic enzymes
12/28/1988	EP0296892A2 Novel linear derivatives of arginine vasopressin antagonists
12/28/1988	EP0296581A2 Amino acid 1,2-diketo derivatives as renin inhibitors
12/28/1988	EP0296574A2 Cholecystokinin analogs for controlling appetite
12/28/1988	EP0296413A2 Hybrid protein C and method for its preparation
12/28/1988	EP0296359A1 Process for preparing a sterilized liquid composition based on casein
12/28/1988	EP0296222A1 A method of modifiying the metabolism of eukaryotic cells upon incorporation therein of foreign sequences of nucleic acids by means of an internalizing vector
12/28/1988	EP0296173A1 Compositions for cosmetic and therapeutic uses containing metal ions or metal ion complexes that form a redox chain
12/28/1988	EP0213180A4 Neovascularization inhibitors and methods for their production and use.
12/28/1988	CN88101606A Treatment of human viral infection by dsrna combined with viral inhibitors
12/28/1988	CA1247611A 1,5-benzoxazepine derivatives
12/28/1988	CA1247605A Crf analogs
12/28/1988	CA1247604A Ovine growth hormone releasing factor
12/28/1988	CA1247603A Cgrp and homolog
12/28/1988	CA1247602A Rcrf and analogs
12/28/1988	CA1247601A Rat grf and analogs
12/28/1988	CA1247600A Urotensin peptides
12/28/1988	CA1247599A Mammalian pgrf
12/28/1988	CA1247546A Cyclosporins
12/28/1988	CA1247545A Insulin derivatives modified in the b 30 position, processes for their preparation and their use, and pharmaceutical agents for the treatment of diabetes mellitus
12/28/1988	CA1247537A Monoclonal antibodies to peptidoglycan and methods of preparing same
12/28/1988	CA1247527A High titer pseudomonas immune serum globulin
12/28/1988	CA1247526A Pancreatic enzyme products and a process for the preparation thereof
12/28/1988	CA1247525A Method and composition for the therapeutic and prophylactic treatment of trauma to the skin
12/28/1988	CA1247521A Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mrnas, receptors, methods and diagnostics using the same
12/27/1988	US4794170 Method for the preparation of conjugates of adenine-9-beta-arabinofuranoside 5' monophosphate with lactosaminated human albumin, the obtained conjugates and therapeutically active compositions containing them
12/27/1988	US4794169 Pentapeptides with cell growth regulatory effects and a process for the preparation thereof
12/27/1988	US4794104 Injection
12/27/1988	US4794103 Pharmaceutical compositions containing peptides of the cholecystokinin-cerulein group for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies
12/27/1988	US4793995 Modified (1-56) beta interferons
12/22/1988	DE3819539A1 Inhibitoren von neutraler endopeptidase Inhibitors of neutral endopeptidase
12/21/1988	EP0296123A2 Cyclic peptolides
12/21/1988	EP0296122A2 Cyclosporins and their use as pharmaceuticals
12/21/1988	EP0296082A1 Active agent and medicine containing it, for preventing or combating organ graft rejection in humans
12/21/1988	EP0296059A1 Tripeptides with a polycyclic nitrogen strusture, their process of preparation and the pharmaceutical compositions thereof
12/21/1988	EP0295962A2 Protein-polysaccharide for treating retroviral infections
12/21/1988	EP0295956A2 Use of a protein-bound polysaccharide for making a drug for treating AIDS.
12/21/1988	EP0295955A2 Lectins and antiretroviral drugs containing the lectins as active ingredients
12/21/1988	EP0295940A2 Method of suppressing the thermal degradation of urokinase
12/21/1988	EP0295826A1 Method of using superoxide dismutase during surgical procedures
12/21/1988	EP0295803A1 Monoclonal antibodies
12/21/1988	EP0295749A1 Sulpholipopolysaccharides as stimulators of the non-specific defence mechanism
12/21/1988	EP0295721A2 Promotion of healing of meniscal tissue
12/21/1988	EP0295679A2 Physiologically-active novel peptides
12/21/1988	EP0295597A2 Factor VIII:C-like molecule with a coagulant activity
12/21/1988	EP0295559A2 Pharmaceutical composition for the treatment of tumours
12/21/1988	EP0295317A1 Pharmaceutical composition for the treatment of tumors
12/21/1988	EP0295316A2 Antitumor amino acid and peptide derivatives of 1,4-bis[ (aminoalkyl and hydroxyaminoalkyl)- amino]-5,8 dihydroxyanthraquinones
12/21/1988	EP0295294A1 Peptidylaminodiols
12/21/1988	CN88103015A Cyclic anticoagulant peptides
12/21/1988	CN88103009A Cyclic anticoagulant peptides
12/20/1988	US4792549 Composition of amino acids
12/20/1988	US4792525 Cell attachment
12/20/1988	US4792447 Specific against cells containing corresponding immunoglobuzins to conjugate
12/20/1988	CA1247090A1 Tissue protein pp in18 xx, a process for obtaining it, and its use
12/20/1988	CA1247089A1 Peptide derivatives
12/20/1988	CA1247088A1 Oligopeptide prodrugs
12/20/1988	CA1247087A1 Chromophoric peptides, a process for their preparation, agents containing them and their use for determining dd-carboxypeptidases
12/20/1988	CA1247086A1 Renally active tetrapeptides
12/20/1988	CA1247085A1 Process for preparing n-carboxyalkylproline- containing tripeptides
12/20/1988	CA1247084A1 Peptide process for preparation thereof and use thereof
12/20/1988	CA1247083A1 Peptide, process for preparation thereof and use thereof
12/20/1988	CA1247010A1 Fibronectin-dextran-drug complex and method of preparation thereof
12/20/1988	CA1247007A1 Treatment of collagenous tissue
12/20/1988	CA1247006A1 Dialysis solutions containing cross-linked gelatin
12/20/1988	CA1247004A1 Method of diagnosis and treatment of leprosy utilizing lymphokines
12/15/1988	WO1988009820A1 Dna sequences, recombinant dna molecules and processes for producing lymphocyte function associated antigen-3
12/15/1988	WO1988009818A2 Growth hormone receptor
12/15/1988	WO1988009817A1 Cloning and expression of human tissue factor
12/15/1988	WO1988009815A1 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation
12/15/1988	WO1988009813A1 Novel proteins with factor viii activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
12/15/1988	WO1988009811A1 Proteins and derivatives thereof
12/15/1988	WO1988009797A1 Autocrine motility factors in cancer diagnosis and management
12/15/1988	WO1988009780A2 Polypeptide compounds having growth hormone releasing activity
12/15/1988	WO1988009674A1 Stabilized formulations of gamma interferons
12/15/1988	WO1988009673A1 Treatment of chronic type b hepatitis with a combination of recombinant human alpha and gamma interferons
12/15/1988	WO1988009672A1 Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
12/15/1988	WO1988009671A1 Active agent and drug containing it for preventing or combating rejection of a transplanted organ in humans
12/15/1988	WO1988009668A1 Treatment and diagnosis of footrot using the basic protease of b. nodosus
12/15/1988	WO1988009666A1 Factor which inhibits in vivo tumoral proliferation, and substances containing it, in particular obtainable from bone marrow
12/15/1988	WO1988009606A2 Pharmaceutical methods involving thyrotropin-releasing hormone analogs
12/15/1988	WO1988009604A2 Thyrotropin-releasing hormone analogs in cns injury
12/15/1988	WO1988009378A3 Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof
12/15/1988	DE3717329A1 Cardiodilatin fragment, process for obtaining it and its use
12/15/1988	DE3249658C2 Carcinoma therapeutic agent

1 ... 3066 3067 3068 3069 3070 3071 3072 3073 3074 3075 3076 3077 3078 3079 3080 3081 3082 3083 3084 3085 3086 ... 3163